New review confirms psychiatric safety of commonly used glucagon-like peptide 1 receptor agonists among patients without ...

inhibitors and glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in certain circumstances, along with a host of recommendations for diet, exercise, alcohol use, and public policy changes to ...

"It will also be important to investigate the impact of GLP-1 RAs on different types of cancer ... nutritious eating and regular physical activity is "the foundation for cancer prevention and ...

The South had the highest ... different body types. The potential causes of the shifts in prevalence should also be looked into to determine whether the shift came from increased use of GLP-1 RAs ...

Encountering retained gastric contents during esophagogastroduodenoscopy (EGD) is more common in patients taking glucagon-like peptide 1 receptor agonists (GLP-1 RAs) but rarely leads to procedure ...

Yunwen Xu, Ph.D., from the Johns Hopkins Bloomberg School of Public Health in Baltimore, and colleagues characterized trends in obesity and prescriptions for GLP-1 RAs across body mass index (BMI ...